Stock Futures Dip Modestly After Record Highs; Texas Instruments Shines
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy INTC?
Source: CNBC
- Texas Instruments Earnings Surge: Texas Instruments has eliminated the overhang on its industrial business, with its data center segment growing 90% year-over-year, and a strong second-quarter guide has led to a premarket share price increase of over 10%, reflecting market confidence in its growth trajectory.
- Honeywell's Disappointing Quarter: Honeywell reported a messy quarter, causing its shares to drop over 5% in premarket trading; however, the upcoming aerospace spin-off scheduled for June 29 keeps long-term investors optimistic about its future potential.
- ServiceNow Shares Plummet: Following a noisy earnings report, ServiceNow's shares fell nearly 14% in premarket trading, as the market expressed concerns over slowed growth and high AI costs, prompting KeyBanc and Jefferies to lower their price targets significantly.
- IBM Revenue Growth Deceleration: IBM's first-quarter revenue growth slowed to 9% from 12% in the previous quarter, raising investor concerns about its future prospects, leading to a premarket decline of over 7% in its stock price, as doubts linger about the effectiveness of its AI tools in maintaining revenue streams.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INTC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INTC
Wall Street analysts forecast INTC stock price to fall
29 Analyst Rating
5 Buy
19 Hold
5 Sell
Hold
Current: 82.540
Low
20.00
Averages
39.30
High
52.00
Current: 82.540
Low
20.00
Averages
39.30
High
52.00
About INTC
Intel Corporation is a global designer and manufacturer of semiconductor products. The Company's segments include Intel Products, Intel Foundry, and All Other. Its Intel Products comprise Client Computing Group (CCG) and Data Center and AI (DCAI). CCG delivers platforms and processors that power PCs and edge devices, enabling enhanced performance, connectivity and user experience for consumer and commercial markets with capabilities that also support retail, industrial robotics and AI ecosystems at the edge. DCAI delivers workload-optimized solutions based upon its x86 architecture for data centers, including CPUs, AI accelerators, NICs, IPUs and custom ASICs, enabling performance and scalability for cloud, enterprise, telecommunication and HPC environments. The Intel Foundry segment comprises technology development, manufacturing and foundry services, developing new semiconductor process technologies and advanced packaging technologies. All Other segments include Mobileye and Other.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Intel Reports Strong Q1 2026 Earnings and Revenue Growth
- Strong Financial Performance: Intel's Q1 2026 report reveals revenue of $13.6 billion, a 7% year-over-year increase, indicating robust market performance that is likely to bolster investor confidence moving forward.
- Earnings Per Share: The company reported an earnings per share (EPS) of $0.73 for the quarter, with a non-GAAP EPS of $0.29, demonstrating profitability despite market challenges, reflecting successful cost control and operational efficiency.
- Optimistic Future Outlook: Management forecasts Q2 2026 revenue between $13.8 billion and $14.8 billion, with expected EPS of $0.08 and non-GAAP EPS of $0.20, suggesting a positive growth trajectory that may attract further investor interest.
- Product Line Expansion: Intel launched several new processors, including the Xeon 600 series and Core Ultra series, enhancing its product portfolio and strengthening its competitive position in the workstation and mobile markets, which is expected to drive sales growth and increase market share.
See More
Market Dynamics and Corporate Acquisition Insights
- Market Stability: Despite rising oil prices due to stalled Iran peace talks, stock futures remain flat this morning, indicating a cautious investor sentiment following a historically volatile week.
- Legal Battle Intensifies: The trial between Elon Musk and Sam Altman begins today, with Musk suing Altman for $134 billion, alleging a breach of promise to keep ChatGPT a nonprofit, which could impact future IPO plans for both companies.
- Stock Price Surge: Qualcomm shares jumped 8% this morning on reports of a partnership with OpenAI to develop smartphone processing chips, highlighting OpenAI's intent to expand into hardware with its planned smartphone launch.
- Acquisition Proposal Surge: Sun Pharmaceutical's all-cash acquisition bid of $11.75 billion for Organon has led to a 17% increase in Organon's stock price this morning, reflecting strong market interest in the women's health sector.
See More
Fiscal Crisis Deepens in Developed Nations
- Deficit Warning: The IMF cautions that public debt in developed countries has reached its highest levels in decades, with the U.S. budget deficit projected to widen from 6% to 7% of GDP over the next decade, highlighting the urgency and instability of fiscal policies.
- Rising Military Spending: NATO allies plan to increase defense spending to 5% of GDP by 2035, while China's industrial policy accounts for approximately 4% of GDP annually, indicating that fiscal expenditures will continue to rise amid escalating resource nationalism and technological competition.
- Market Risk Underpricing: BNP Paribas strategists note that current market pricing of fiscal risks is
See More
NASDAQ 100 Pre-Market Activity Overview
- Market Performance: The NASDAQ 100 Pre-Market Indicator is down 22.14 points to 27,281.53, indicating cautious market sentiment that may influence short-term investor decisions.
- Active Stocks: Organon & Co. (OGN) rises by $1.91 to $13.17 with a trading volume of 34,420,118 shares, currently priced at 146.33% of its target price, reflecting optimistic market expectations for its future performance.
- Earnings Forecast: Intel Corporation (INTC) has had three upward revisions in earnings forecasts over the past four weeks, with a current stock price of $82.86 and an expected EPS of $0.08 for the fiscal quarter ending June 2027, showcasing market confidence in its future profitability.
- Short Interest Data: Sagimet Biosciences Inc. (SGMT) and Intellia Therapeutics, Inc. (NTLA) have days to cover of 10.41 and 15.42 respectively, indicating high short-term trading activity for these stocks, which may impact their price volatility.
See More
Major Wall Street Rating Updates on Monday
- Cohu Rating Reiteration: Jefferies reiterates its Buy rating on Cohu with a price target of $55, viewing the company as an emerging enabler of higher-complexity semiconductor testing, which could enhance its market position significantly.
- Rollins Upgrade: Rothschild & Co Redburn upgrades Rollins from Neutral to Buy, raising the price target from $51.90 to $66, indicating a 16% upside, as they see the current share price as an attractive entry point for investors.
- Nutrien Upgrade: Barclays upgrades Nutrien from Equal Weight to Overweight, increasing the price target from $80 to $85, anticipating continued strength in the nitrogen segment due to the Iran conflict, which positions the company favorably in the market.
- Galaxy Digital Initiation: Chardan initiates coverage of Galaxy Digital with a Buy rating, highlighting its attractive position in the digital asset ecosystem and potential for integration with traditional financial markets, which could drive future growth.
See More
Intel's Chief Accounting Officer Resigns
- Executive Change: Intel's Chief Accounting Officer Scott Gawel has resigned effective immediately, indicating a significant shift in the company's executive team that could impact financial management stability.
- Succession Plan: Intel's CFO David Zinsner will assume the role of Principal Accounting Officer, a move aimed at ensuring continuity in financial functions, which may help alleviate market concerns regarding leadership changes.
- Stock Price Reaction: Following the announcement, Intel shares rose 2% in premarket trading on Monday, reflecting a positive investor response to the management adjustment and possibly indicating confidence in the new Principal Accounting Officer.
- Industry Context: Given the strong performance of the semiconductor sector, Intel's executive transition could influence its performance on the Nasdaq, especially as the index hits record highs, leading investors to have heightened expectations for the company's future performance.
See More
Intel Reports Strong Q1 2026 Earnings and Revenue Growth
- Strong Financial Performance: Intel's Q1 2026 report reveals revenue of $13.6 billion, a 7% year-over-year increase, indicating robust market performance that is likely to bolster investor confidence moving forward.
- Earnings Per Share: The company reported an earnings per share (EPS) of $0.73 for the quarter, with a non-GAAP EPS of $0.29, demonstrating profitability despite market challenges, reflecting successful cost control and operational efficiency.
- Optimistic Future Outlook: Management forecasts Q2 2026 revenue between $13.8 billion and $14.8 billion, with expected EPS of $0.08 and non-GAAP EPS of $0.20, suggesting a positive growth trajectory that may attract further investor interest.
- Product Line Expansion: Intel launched several new processors, including the Xeon 600 series and Core Ultra series, enhancing its product portfolio and strengthening its competitive position in the workstation and mobile markets, which is expected to drive sales growth and increase market share.
See More
Market Dynamics and Corporate Acquisition Insights
- Market Stability: Despite rising oil prices due to stalled Iran peace talks, stock futures remain flat this morning, indicating a cautious investor sentiment following a historically volatile week.
- Legal Battle Intensifies: The trial between Elon Musk and Sam Altman begins today, with Musk suing Altman for $134 billion, alleging a breach of promise to keep ChatGPT a nonprofit, which could impact future IPO plans for both companies.
- Stock Price Surge: Qualcomm shares jumped 8% this morning on reports of a partnership with OpenAI to develop smartphone processing chips, highlighting OpenAI's intent to expand into hardware with its planned smartphone launch.
- Acquisition Proposal Surge: Sun Pharmaceutical's all-cash acquisition bid of $11.75 billion for Organon has led to a 17% increase in Organon's stock price this morning, reflecting strong market interest in the women's health sector.
See More
Fiscal Crisis Deepens in Developed Nations
- Deficit Warning: The IMF cautions that public debt in developed countries has reached its highest levels in decades, with the U.S. budget deficit projected to widen from 6% to 7% of GDP over the next decade, highlighting the urgency and instability of fiscal policies.
- Rising Military Spending: NATO allies plan to increase defense spending to 5% of GDP by 2035, while China's industrial policy accounts for approximately 4% of GDP annually, indicating that fiscal expenditures will continue to rise amid escalating resource nationalism and technological competition.
- Market Risk Underpricing: BNP Paribas strategists note that current market pricing of fiscal risks is
See More
NASDAQ 100 Pre-Market Activity Overview
- Market Performance: The NASDAQ 100 Pre-Market Indicator is down 22.14 points to 27,281.53, indicating cautious market sentiment that may influence short-term investor decisions.
- Active Stocks: Organon & Co. (OGN) rises by $1.91 to $13.17 with a trading volume of 34,420,118 shares, currently priced at 146.33% of its target price, reflecting optimistic market expectations for its future performance.
- Earnings Forecast: Intel Corporation (INTC) has had three upward revisions in earnings forecasts over the past four weeks, with a current stock price of $82.86 and an expected EPS of $0.08 for the fiscal quarter ending June 2027, showcasing market confidence in its future profitability.
- Short Interest Data: Sagimet Biosciences Inc. (SGMT) and Intellia Therapeutics, Inc. (NTLA) have days to cover of 10.41 and 15.42 respectively, indicating high short-term trading activity for these stocks, which may impact their price volatility.
See More
Major Wall Street Rating Updates on Monday
- Cohu Rating Reiteration: Jefferies reiterates its Buy rating on Cohu with a price target of $55, viewing the company as an emerging enabler of higher-complexity semiconductor testing, which could enhance its market position significantly.
- Rollins Upgrade: Rothschild & Co Redburn upgrades Rollins from Neutral to Buy, raising the price target from $51.90 to $66, indicating a 16% upside, as they see the current share price as an attractive entry point for investors.
- Nutrien Upgrade: Barclays upgrades Nutrien from Equal Weight to Overweight, increasing the price target from $80 to $85, anticipating continued strength in the nitrogen segment due to the Iran conflict, which positions the company favorably in the market.
- Galaxy Digital Initiation: Chardan initiates coverage of Galaxy Digital with a Buy rating, highlighting its attractive position in the digital asset ecosystem and potential for integration with traditional financial markets, which could drive future growth.
See More
Intel's Chief Accounting Officer Resigns
- Executive Change: Intel's Chief Accounting Officer Scott Gawel has resigned effective immediately, indicating a significant shift in the company's executive team that could impact financial management stability.
- Succession Plan: Intel's CFO David Zinsner will assume the role of Principal Accounting Officer, a move aimed at ensuring continuity in financial functions, which may help alleviate market concerns regarding leadership changes.
- Stock Price Reaction: Following the announcement, Intel shares rose 2% in premarket trading on Monday, reflecting a positive investor response to the management adjustment and possibly indicating confidence in the new Principal Accounting Officer.
- Industry Context: Given the strong performance of the semiconductor sector, Intel's executive transition could influence its performance on the Nasdaq, especially as the index hits record highs, leading investors to have heightened expectations for the company's future performance.
See More
